Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

Title	Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
Publication Type	Journal Article
Year of Publication	2016
Authors	Cruz, F
Journal	European Urology
Volume	70
Issue	5
Pagination	892
Date Published	2016
URL	https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994300338&doi=10.1016%2fj.eururo.2016.08.027&partnerID=40&md5=767675236ae208f3e9878f8c1dacca08

Group:

Search form